The global Difficile Infections Treatment Market by 2033, amount to US$1,448.75 million USD. This is based on a projected compound annual growth rate (CAGR) of 6% from a US$809 million 2023 valuation. This surge is a result of both the increasing frequency of CDI and advancements in diagnostic techniques. The bacteria responsible for CDI, or diarrheal …
Tag Archives: Difficile Infections (Clostridium Difficile Associated Disease) Market Analysis
Global Difficile Infections Treatment Market Set to Surge, Projected to Reach US$ 1,448.75 Million at a CAGR of 6% predicted from 2023 to 2033
The global Difficile Infections Treatment Market also known as Clostridium Difficile Associated Disease (CDAD), is anticipated to reach a value of US$809 million in 2023. This market is expected to exhibit steady growth with a compound annual growth rate (CAGR) of 6% projected from 2023 to 2033. Difficile infections are caused by the bacterium Clostridium …